Invited by Sanofi, SINO-PhIRDA delegation visited the company’s headquarter in Paris, France July 7, 2014.

Led by Dr. Yan Xijun (Chairman, SINO-PhIRDA & Tasly Holding Group Co., Ltd) and Prof. Song Ruilin (Executive President, SINO-PhIRDA), the delegation included Mr. Wang Yong (Chairman, Nanjing Sanhome Pharmaceutical Co.,Ltd), Mr. Lou Jing (Chairman & CEO, Shenyang Sunshine Pharmaceutical Co.,Ltd), Ms. Wu Naifeng (CEO, Tasly Holding Group Co., Ltd), Mr. Sun He (Vice President, Tasly Holding Group Co., Ltd), Mr. Guo Dianwu (Chief Scientist, Hangzhou Minsheng Pharmaceutical Co. ,Ltd), Mr. Zhao Xingping (Director & Vice President, Kanghong Pharmaceutical Group Co., Ltd), Ms. Feng Lan (Deputy Secretary-General, SINO-PhIRDA), Ms. Liu Weina (International BD Manager, Yabao Pharmaceutical Group Co., Ltd), Mr. Wang Xin (Deputy Senior Director, SINO-PhIRDA) and Mr. Shan Yiduo (Assistant to Chairman, Tasly Holding Group Co., Ltd).

The delegation met with Mr. Peter Guenter (Executive VP, Global Commercial Operations), Mr. Jean-Luc Lowinski (Senior VP, Asia) and other senior representatives from Sanofi, discussing about collaboration on pharmaceutical innovation between the two sides.

<1> Dr. Yan Xijun (Chairman, SINO-PhIRDA & Tasly Holding Group Co., Ltd) gave speech

<2> Prof. Song Ruilin (Executive President, SINO-PhIRDA) gave speech

<3> Mr. Zhao Xingping (Director & Vice President, Kanghong Pharmaceutical Group Co., Ltd) gave speech

<4> Mr. Jean-Luc Lowinski (Senior VP, Asia, Sanofi) gave speech

<5> Mr. Philippe Tcheng (Vice President, Sanofi) gave speech

<6> SINO-PhIRDA delegates and Sanofi representatives